Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Randomized Trial

NCT02024191 is registered in ClinicalTrials.gov with Ankara Education and Research Hospital as lead sponsor.

NCT NCT02024191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Randomized Trial
Lead sponsor
Ankara Education and Research Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2013
Completion date
June 30, 2015
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy